Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (June 2010)
8 slides from Advanced Medical Solutions's shareholder meeting presentation, Jun 2, 2010
Slide 1: Annual General Meeting - Building for success
Annual General Meeting 2nd June 2010 Building for success
Slide 2: Welcome to AMS (AIM: AMS.L)
Welcome to AMS (AIM: AMS.L) A global medical device company currently focused on the woundcare, wound closure and sealant markets 241 employees across three locations: Winsford, Plymouth and Etten Leur (Holland) Multi-product portfolio backed by strong IP, know-how and regulatory approvals Multiple
Slide 3: 2009 Operational Highlights
2009 Operational Highlights New world class facility within budget and on schedule to open by end 2010. First US sales of LiquiBand™. Cardinal Health signed as part of multi-partner distribution strategy for penetration of US tissue adhesives market. SilverCel™ Non-Adherent launched by Systagenix. A
Slide 4: 2009 Financial Results - Summary
2009 Financial Results - Summary Group revenue & profit 2004 – 2009 (£m) 25 PBT Advanced Woundcare Wound Closure & Sealants 4.7 20 Revenue up 19% to £24.1 million 3.9 15 4.1 Gross profit up 19% to £11.6 million 10 2.1 2.4 2.9 15.3 13.5 Operating profit* up 51% to £4.1 million 10.9 10.9 11.0 5 8.9 4.
Slide 5: Strategy - Building For Success
Strategy Continue to broaden product range Higher performance dressings Technologies to accelerate wound healing Support global blue chip partner base Product development assistance Technical, regulatory and clinical support Review licensing and acquisition opportunities Access new material technolo
Slide 6: Strategy - Building For Success
Strategy Increase penetration of US tissue adhesive market Maintain a leadership position Tissue adhesives Applicator design Broaden global reach Enter internal adhesives market Evaluate licensing and acquisition opportunities Access new material technologies Broaden direct sales presence Building F
Slide 7: Summary
Summary Building blocks continue to be put in place to achieve strategic growth objectives New facility on time and on budget for year-end. One of existing facilities vacated and all processes now transferred and operational Positive progress on LiquiBand US introduction Three more distributors add
Slide 8: Outlook
Outlook The strong start to the year has continued during the first half Trading substantially ahead of last year and in line with current market expectations for the full year 2010 Details of the dividend policy to be confirmed at the Interims in September The outlook remains very positive AMS is a
Advanced Medical Solutions Group — Shareholder Meeting (June 2010) on 6ix